FLASH SALES

NAFDAC Raises Alarm Over Counterfeit Paracetamol Injection, Incorrectly Labeled as Antibacterial

Medinat
By Medinat - Editor
NAFDAC Raises Alarm Over Counterfeit Paracetamol Injection, Incorrectly Labeled as Antibacterial

NAFDAC has issued a public alert regarding the presence of falsified paracetamol injection being sold under the misleading label “Paracetamol Injection 300mg/2ml I.M I.V Aminoglycoside Antibacterial.”

The discovery of this counterfeit product came to light during a surveillance operation conducted by NAFDAC’s post-marketing surveillance unit in FCT, Abuja.

Upon sampling for laboratory analysis, NAFDAC Laboratory Kaduna confirmed that the product only contained paracetamol, despite its misleading labeling as an aminoglycoside antibacterial.

It’s crucial to understand that paracetamol injection is primarily used as an analgesic and antipyretic to alleviate mild to moderate pain and fever. On the other hand, aminoglycosides are a class of antibiotics reserved for treating severe bacterial infections.

Contrary to the false labeling, NAFDAC emphasized that the genuine Paracetamol Injection 300mg/2ml I.M I.V is manufactured by Shandong Shenglu Pharm. Co. Ltd, China, and distributed by Sifam Life Care Pharmaceutical Ltd., Kano, Nigeria.

Furthermore, NAFDAC clarified that the authentic product is registered solely as an analgesic and not as an aminoglycoside antibacterial, as erroneously indicated on the counterfeit packaging.

The certificate of registration issued by NAFDAC has officially confirmed the fraudulent nature of the misrepresented paracetamol injection.

In light of this alarming discovery, NAFDAC advises the public to exercise caution and verify the authenticity of pharmaceutical products before use, particularly when there are discrepancies in labeling or packaging. Vigilance is crucial in safeguarding public health and preventing the consumption of counterfeit or substandard medications.

Share This Article
Leave a comment